ATF4-Glutamine轴:癌症代谢,应激适应和治疗向中的一个中心节点
1The Second Affiliated Hospital of Dalian Medical University Thoracic surgery, DaLian, Liaoning, PR China.
Cell death discovery
|August 19, 2025
概括
激活转录因子4 (ATF4) 通过调节谷氨胺 (Gln) 代谢来驱动癌细胞的生存. 向ATF4-Gln轴为癌症治疗提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 激活转录因子4 (ATF4) 是瘤代谢适应的中央调节者.
- 在营养缺乏和氧化应激期间,ATF4控制着谷氨胺 (Gln) 的吸收,利用和氧化还原平衡.
研究的目的:
- 审查ATF4在整合压力信号中的作用,以调节癌症中的Gln代谢.
- 突出ATF4-Gln轴作为潜在的治疗漏洞.
主要方法:
- 对癌症中ATF4和Gln代谢的临床前研究的文献综述.
- 分析ATF4在瘤存活,代谢重编程和免疫逃避中的作用.
主要成果:
- ATF4-Gln轴对瘤存活和代谢适应至关重要.
- 针对这种途径的临床前抑制剂显示出治疗前景.
- 了解这一轴可以为新的癌症疗法提供见解.
结论:
- ATF4-Gln轴在癌症新陈代谢中具有显著的脆弱性.
- 针对ATF4提供了新的治疗策略的潜力.
- 未来的研究应该解决瘤异质性和可塑性,以获得有效的ATF4中心疗法.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Hypothalamic-Pituitary Axis
61.6K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
61.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K


